State of Wyoming’s ADC Therapeutics ADCT Stock Holding History

State of Wyoming’s Portfolio ADCT Stock Details ADCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.62K	Buy	+2,032	New	+$8.01K	﹤0.01%	1734
2025 Q1	–	Sell	-8,267	Closed	-$16.5K	–	1626
2024 Q4	$16.5K	Buy	+8,267	New	+$21.6K	﹤0.01%	1526
2024 Q3	–	Sell	-6,221	Closed	-$19.7K	–	1675
2024 Q2	$19.7K	Buy	+6,221	New	+$24.7K	﹤0.01%	1552
2022 Q2	–	Sell	-2,882	Closed	-$42K	–	1838
2022 Q1	$42K	Buy	2,882 +1,057	+58%	+$16.8K	0.02%	1144
2021 Q4	$37K	Buy	1,825 +276	+18%	+$6.66K	0.02%	1237
2021 Q3	$42K	Sell	1,549 -807	-34%	-$20.7K	0.03%	800
2021 Q2	$57K	Buy	2,356 +1,481	+169%	+$34.4K	0.04%	707
2021 Q1	$21K	Buy	+875	New	+$25.3K	0.03%	307

Other funds holding ADCT

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State of Wyoming's ADCT Position: Q1 2026 in Review

State of Wyoming opened a new position in ADC Therapeutics (ADCT) in Q1 2026: 2,032 shares worth $7.62K. The stake represents ﹤0.01% of the portfolio and ranks #1734 among its holdings. This is a return to the name: State of Wyoming previously reported a position in ADCT as recently as Q4 2024.

State of Wyoming first reported a position in ADCT in Q1 2021 and has held it in 8 quarters since. The position peaked at $57K in Q2 2021. 118 funds tracked by Wall St. Rank hold ADCT as of Q1 2026.

State of Wyoming held 2,032 shares of ADC Therapeutics worth $7.62K as of Q1 2026.
ADC Therapeutics was a new State of Wyoming position in Q1 2026.
ADC Therapeutics made up ﹤0.01% of State of Wyoming's portfolio in Q1 2026, its #1734 holding.
State of Wyoming first reported a position in ADC Therapeutics in Q1 2021 and has held it in 8 quarters since.
State of Wyoming's ADC Therapeutics position peaked at $57K in Q2 2021.
118 funds tracked by Wall St. Rank held ADC Therapeutics as of Q1 2026.

Based on State of Wyoming's 13F filing for Q1 2026, filed 13 May 2026.